HVT-based multiepitope vaccine administered subcutaneously or in ovo boosts protection of inactivated H9N2 vaccine against heterologous virus. - Xie Z; Chen Y; Du S; Huang X; Shao Y; Huang J; Liao M; Dai M (Virologica Sinica, 2026)